Autonomix Medical, Inc. Common Stock
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a AMIX research report →
Companyautonomix.com
Autonomix Medical, Inc. , a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals.
- CEO
- Bradley Hauser
- IPO
- 2024
- Employees
- 5
- HQ
- The Woodlands, US
Price Chart
Valuation
- Market Cap
- $1.73M
- P/E
- -0.17
- P/S
- 0.00
- P/B
- 0.35
- EV/EBITDA
- 0.48
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -228.82%
- ROIC
- -205.00%
Growth & Income
- Revenue
- $0 · 0.00%
- Net Income
- $-11,410,000 · 26.03%
- EPS
- $-6.46 · 69.38%
- Op Income
- $-11,588,000
- FCF YoY
- -24.07%
Performance & Tape
- 52W High
- $2.64
- 52W Low
- $0.20
- 50D MA
- $0.39
- 200D MA
- $0.72
- Beta
- -1.80
- Avg Volume
- 627.87K
Get TickerSpark's AI analysis on AMIX
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Aug 11, 25 | Hauser Bradley | sell | 45,000 |
| Aug 11, 25 | Capelli Christopher | sell | 3,750 |
| Aug 11, 25 | KLEMP WALTER V | sell | 8,773 |
| Aug 11, 25 | Bisson Lori | sell | 18,862 |
| Aug 11, 25 | Bisson Lori | sell | 46,680 |
| Aug 11, 25 | Smith Trent N. | sell | 11,405 |
| Aug 11, 25 | Smith Trent N. | sell | 21,250 |
| Jan 26, 24 | Smith Trent N. | other | 0 |
| Jan 26, 24 | Smith Trent N. | other | 425,000 |
| Oct 11, 23 | Smith Trent N. | other | 25,000 |
Our AMIX Coverage
We haven't published any research on AMIX yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate AMIX Report →